HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Frisso, G. Articles by Sacchetti, L. Search for Related Content PubMed PubMed Citation Articles by Frisso, G. Articles by Sacchetti, L. Related Collections Molecular Diagnostics and Genetics

Direct Detection of Exon Deletions/Duplications in Female Carriers of and Male Patients with Duchenne/Becker Muscular Dystrophy

Dipartimento di Biochimica e Biotecnologie Mediche and CEINGE Biotecnologie Avanzate, Università Federico II, Naples, Italy

^aaddress correspondence to this author at: Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli Federico II, and CEINGE Biotecnologie Avanzate, Via S Pansini 5, 80131 Napoli, Italy; fax 39-81-7462404, e-mail sacchetti@dbbm.unina.it

The first 300 words of the full text of this article appear below.

Duchenne and Becker muscular dystrophies (DMD/BMD) are X-linked allelic neuromuscular disorders that have a prevalence of 1 in 3500 live-born males. The genetic defect is the result of mutations of the dystrophin gene, which encodes a 427-kDa rod-shaped cytoskeletal protein (1). The locus is very unstable: one-third of all DMD/BMD cases represent new mutations without a family history of the disease (1). Approximately 50–70% of DMD/BMD cases are the result of macrodeletions, and partial gene duplications have been reported in 6% of patients (2). Both macrodeletions and macroduplications are preferentially clustered in two areas, the amino-terminal (exons 3–7) and the central (exons 44–55) regions (1). The remaining cases are presumably attributable to point mutations or small insertions/deletions (2) scattered along the entire gene. PCR detection of macrodeletions is very useful in the analysis of affected males (3)(4), but it provides no information about the carrier status of at-risk women. Carrier status within families is usually assessed by haplotype analysis (5), fluorescence in situ hybridization (6), amplification of ectopic transcripts (7)(8), dosage analysis on Southern blots (9), or separation of quantitative PCR products by gel electrophoresis (10). Semiquantitative methods, based on the separation of fluorescently labeled amplified exons by gel or capillary electrophoresis, are also available (11)(12)(13)(14)(15).

Here we report a quantitative PCR method, followed by separation by capillary gel electrophoresis of the fluorescently labeled amplified exons of hot spot regions of the dystrophin gene, which allowed us to detect 99% patients (affected males and female carriers) with macrodeletions and 89% with macroduplications, and to identify small insertions or deletions in those regions. This method . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				A. Carsana, G. Frisso, M. R. Tremolaterra, E. Ricci, D. De Rasmo, and F. Salvatore A Larger Spectrum of Intragenic Short Tandem Repeats Improves Linkage Analysis and Localization of Intragenic Recombination Detection in the Dystrophin Gene: An Analysis of 93 Families from Southern Italy J. Mol. Diagn., February 1, 2007; 9(1): 64 - 69. [Abstract] [Full Text] [PDF]

				C.-C. Hung, Y.-N. Su, C.-Y. Lin, C.-C. Yang, W.-T. Lee, S.-C. Chien, W.-L. Lin, and C.-N. Lee Denaturing HPLC Coupled with Multiplex PCR for Rapid Detection of Large Deletions in Duchenne Muscular Dystrophy Carriers Clin. Chem., July 1, 2005; 51(7): 1252 - 1256. [Full Text] [PDF]